Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT07231315

INTERACT4 Expansion - Validation Study

Sponsor: The George Institute

View on ClinicalTrials.gov

Summary

As an investigator-initiated and conducted, multi-centre, open-label, single-arm prospective observational trial, INTERACT4 Expansion aims to evaluate the diagnostic accuracy of GFAP measured using a point-of-care device, for identifying ICH in participants presenting with acute stroke-like symptoms in the pre-hospital setting compared with imaging-confirmed ICH.

Official title: INTEnsive Ambulance-delivered Blood Pressure Reduction in Biomarker-identified Hyper-ACute Intracerebral Haemorrhage Trial - Validation Study

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

OBSERVATIONAL

Enrollment

465

Start Date

2026-02-01

Completion Date

2027-06-01

Last Updated

2025-11-19

Healthy Volunteers

No

Interventions

DIAGNOSTIC_TEST

LVOne

LVOne is an in vitro diagnostic rapid lateral flow chromatographic immunoassay kit

Locations (4)

Liverpool Hospital

Sydney, New South Wales, Australia

Nepean Hospital

Sydney, New South Wales, Australia

New South Wales Ambulance

Sydney, New South Wales, Australia

Royal North Shore Hospital

Sydney, New South Wales, Australia